Headlines

MSC2011 will be held August 22-24 in Cleveland, Ohio

The MSC2011 Conference on Regenerative Medicine and Adult Stem Cell Therapy will offer a forum for the exchange and discussion of research, ideas, and cutting-edge breakthroughs in translational regenerative medicine. Become an active part of MSC2011 today—let us know if you have suggestions for speakers or topics, or would like to be involved in planning and implementation. Email registration@mscconference.net or call 1-216-368-2079 to submit your ideas.

News

July 06, 2010
US Scientists Succesful In Creating HIV-Resistant Cells
Link to article

July 06, 2010
New Stem Cell Therapy for Parkinson's Hailed as "A Small Miracle"
Link to article

July 01, 2010
Gene Regulating Human Brain Development Identified
Link to article

more news...

Press Releases

June 25, 2010
Athersys and CSCRM Receive Grant Funding to Support Research Into Novel Stem Cell Treatment of Spinal Cord Injury
Link to article

June 23, 2010
Ohio Third Frontier Awards Support State’s Growing Biomedical Industry
Link to article

April 05, 2010
Juventas Therapeutics Enrolling Phase I Clinical Trial of JVS-100 for Patients with Heart Failure
Link to article

more press releases...

Your email address:    
Cleveland skyline

The National Center for Regenerative Medicine (NCRM) builds upon leading research and clinical programs at its founding institutions—Case Western Reserve University (CWRU), Cleveland Clinic (CC), and University Hospitals Case Medical Center (UHCMC)—in heart disease, cancer, genetic disorders, wound healing, and immunological, musculoskeletal, and neurodegenerative diseases. The combination of a 26-year history of research on adult and pluripotent stem cells, outstanding clinical and research programs, and tested and proven experience of using adult stem cell transplantation to treat patients makes this Center unique in the United States.

Regenerative medicine represents a new form of medicine using stem cells and tissue engineered scaffolds to generate new tissue in diseased or damaged organs--rather than using drugs or devices to improve function and quality of life.

The NCRM is made up of two organizations--the Center for Stem Cell and Regenerative Medicine (CSCRM) and the Clinical Tissue Engineering Center (CTEC). Through investment by the State of Ohio’s Third Frontier Initiative, $41.5 million in funding has been received since 2003 to commercialize stem cell and tissue engineering therapies. $6.6 million in Federal appropriations has strengthened or created nearly 40 multi-institutional core facilities for Center members to access advanced regenerative medicine equipment and accelerate their research and clinical pursuits.

The broad-based excellence of its partner institutions provides the NCRM a comprehensive approach, including basic and clinical research, biomedical and tissue engineering, and the development and administration of new therapies to patients with cancer as well as cardiovascular, blood, bone, immunological and nervous system diseases. The Center seeks to translate innovative laboratory research into the clinical and commercial arenas to replace and repair diseased tissues and organs. NCRM and its partner institutions and affiliated programs provide educational opportunities that enable nurses, graduate students, and technicians to gain the complex skills required to perform ground-breaking research and deliver optimal patient care in this new field. These efforts help create a well-trained workforce for the Center, for new businesses, and for other institutions.